Clinical

Dataset Information

0

Detection of tumor tiSsue in pEritoneal metastases of coLorectal origin using a VEGF-targeted optical fluoresCent imaging tracer during diagnosTic laparoscopy: a single center phase I study


ABSTRACT: Interventions: Single bolus of Bevacizumab-IRDye800CW (2.5 mg, 4.5 mg, 10 mg or 25 mg) intravenously. Primary outcome(s): Degree of fluorescent signal levels (defined as Tumor-to-Background Ratio [TBR]) per dose group, consisting of the difference in signal levels between colorectal PM and normal benign surrounding tissue. Study Design: N/A: single arm study, Open (masking not used), N/A , unknown, Other

DISEASE(S): Colorectal Peritoneal Metastases (pm)

PROVIDER: 2442208 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 18348 | ecrin-mdr-crc
2007-11-15 | GSE6541 | GEO
| S-EPMC10660181 | biostudies-literature
| 2286305 | ecrin-mdr-crc
2012-12-01 | GSE42659 | GEO
2007-12-01 | GSE9465 | GEO
2023-04-23 | GSE228200 | GEO
2008-06-14 | E-GEOD-6541 | biostudies-arrayexpress
2005-10-26 | GSE3499 | GEO
2006-12-31 | GSE3778 | GEO